BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16534812)

  • 1. Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-A resolution.
    Barr AJ; Debreczeni JE; Eswaran J; Knapp S
    Proteins; 2006 Jun; 63(4):1132-6. PubMed ID: 16534812
    [No Abstract]   [Full Text] [Related]  

  • 2. The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors.
    Glover NR; Tracey AS
    Biochem Cell Biol; 2000; 78(1):39-50. PubMed ID: 10735562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional effects of disease-causing amino acid substitutions affecting residues Ala72 and Glu76 of the protein tyrosine phosphatase SHP-2.
    Bocchinfuso G; Stella L; Martinelli S; Flex E; Carta C; Pantaleoni F; Pispisa B; Venanzi M; Tartaglia M; Palleschi A
    Proteins; 2007 Mar; 66(4):963-74. PubMed ID: 17177198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-substrate interactions revealed by the crystal structures of the archaeal Sulfolobus PTP-fold phosphatase and its phosphopeptide complexes.
    Chu HM; Wang AH
    Proteins; 2007 Mar; 66(4):996-1003. PubMed ID: 17173287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of human TMDP, a testis-specific dual specificity protein phosphatase: implications for substrate specificity.
    Kim SJ; Jeong DG; Yoon TS; Son JH; Cho SK; Ryu SE; Kim JH
    Proteins; 2007 Jan; 66(1):239-45. PubMed ID: 17044055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, dynamics and binding characteristics of the second PDZ domain of PTP-BL.
    Walma T; Spronk CA; Tessari M; Aelen J; Schepens J; Hendriks W; Vuister GW
    J Mol Biol; 2002 Mar; 316(5):1101-10. PubMed ID: 11884147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure and regulation of myotubularin phosphatases.
    Begley MJ; Dixon JE
    Curr Opin Struct Biol; 2005 Dec; 15(6):614-20. PubMed ID: 16289848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion.
    Sun JP; Wang WQ; Yang H; Liu S; Liang F; Fedorov AA; Almo SC; Zhang ZY
    Biochemistry; 2005 Sep; 44(36):12009-21. PubMed ID: 16142898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of human DSP18, a member of the dual-specificity protein tyrosine phosphatase family.
    Jeong DG; Cho YH; Yoon TS; Kim JH; Son JH; Ryu SE; Kim SJ
    Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):582-8. PubMed ID: 16699184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The X-ray crystal structure of PA3566 from Pseudomonas aureginosa at 1.8 A resolution.
    Sanders DA; Walker JR; Skarina T; Savchenko A
    Proteins; 2005 Oct; 61(1):209-12. PubMed ID: 16049913
    [No Abstract]   [Full Text] [Related]  

  • 11. The myotubularin family: novel phosphoinositide regulators.
    Nandurkar HH; Huysmans R
    IUBMB Life; 2002 Jan; 53(1):37-43. PubMed ID: 12018406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease.
    Girard JM; Lê KH; Lederer F
    Biochimie; 2006 Dec; 88(12):1961-71. PubMed ID: 17010495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific incorporation of allosteric-inhibition sites in a protein tyrosine phosphatase.
    Zhang XY; Bishop AC
    J Am Chem Soc; 2007 Apr; 129(13):3812-3. PubMed ID: 17346049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
    Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
    Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.
    Wan ZK; Lee J; Xu W; Erbe DV; Joseph-McCarthy D; Follows BC; Zhang YL
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4941-5. PubMed ID: 16806920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energetics of peptide recognition by the second PDZ domain of human protein tyrosine phosphatase 1E.
    Milev S; Bjelić S; Georgiev O; Jelesarov I
    Biochemistry; 2007 Jan; 46(4):1064-78. PubMed ID: 17240990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms.
    Jeong DG; Kim SJ; Kim JH; Son JH; Park MR; Lim SM; Yoon TS; Ryu SE
    J Mol Biol; 2005 Jan; 345(2):401-13. PubMed ID: 15571731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrostatic evaluation of the signature motif (H/V)CX5R(S/T) in protein-tyrosine phosphatases.
    Peters GH; Frimurer TM; Olsen OH
    Biochemistry; 1998 Apr; 37(16):5383-93. PubMed ID: 9548920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of group bulkiness in the catalytic activity of psychrophile cold-active protein tyrosine phosphatase.
    Tsuruta H; Mikami B; Yamamoto C; Yamagata H
    FEBS J; 2008 Sep; 275(17):4317-28. PubMed ID: 18647345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of human dual specificity phosphatase, JNK stimulatory phosphatase-1, at 1.5 A resolution.
    Yokota T; Nara Y; Kashima A; Matsubara K; Misawa S; Kato R; Sugio S
    Proteins; 2007 Feb; 66(2):272-8. PubMed ID: 17068812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.